Clinical Trials
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
SWOG-9107
A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer
Activated
01-01-1993
Closed
08-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9140
Phase II Study of Oral Bropirimine Combined with Intravesical Bacillus Calmette - Guerin (Tice) in Patients with Carcinoma in Situ of the Bladder
Research Committee(s)
Genitourinary Cancer
Activated
12-01-1992
Closed
12-01-1997
Closed
Phase
Accrual
15%
SWOG Clinical Trial Number
SWOG-9101
Evaluation of Edatrexate in Patients with Advanced or Recurrent Bladder Carcinoma, Phase II
Activated
11-15-1992
Closed
11-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9003
Fludarabine for Waldenstrom's Macroglobulinemia (WM): A Phase II Pilot Study for Untreated and Previously Treated Patients
Research Committee(s)
Myeloma
Activated
11-01-1992
Closed
09-01-1998
Closed
Phase
SWOG Clinical Trial Number
SWOG-9205
Central Prostate Cancer Serum Repository Protocol
Research Committee(s)
Genitourinary Cancer
Activated
10-01-1992
Closed
10-01-2006
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9225
Pharmacokinetics of Isotretinoin or All Trans Retinoic Acid: An Ancillary Study to SWOG-9132
Research Committee(s)
Gynecologic Cancer
Activated
09-15-1992
Closed
06-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9132
Evaluation of Alpha Interferon/Isotretinoin or Alpha Interferon/All Trans Retinoic Acid in Cervical Cancer, Phase II
Research Committee(s)
Gynecologic Cancer
Activated
09-15-1992
Closed
05-15-1996
Closed
Phase
Accrual
75%
Published
SWOG Clinical Trial Number
SWOG-9133
Randomized Trial of Subtotal Nodal Irradiation Versus Doxorubicin Plus Vinblastine and Subtotal Nodal Irradiation for Stage I-IIA Hodgkin's Disease, Phase III
Research Committee(s)
Lymphoma
Activated
09-15-1992
Closed
04-24-2000
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-9130
Smoking Cessation for Early Stage Bladder Cancer Patients Using A Combined Brief Physician-Message and Cancer Information Service (CIS) Counseling Approach
Activated
09-01-1992
Closed
08-17-1995
Closed
Phase
Accrual
65%
Published
SWOG Clinical Trial Number
SWOG-9104
Evaluation of Doxorubicin/Vinblastine Combined with Inhibitors (Trifluoperazine/Verapamil) of P-Glycoprotein in Patients with Advanced Renal Cell Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
09-01-1992
Closed
09-01-1994
Closed
Phase
Accrual
47%
SWOG Clinical Trial Number
SWOG-9128
Closed
Phase
Accrual
58%
SWOG Clinical Trial Number
SWOG-9148
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9005
Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma, Phase III
Research Committee(s)
Brain Cancer
Activated
08-15-1992
Closed
07-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9143
Closed
Phase
Accrual
57%
Published
SWOG Clinical Trial Number
SWOG-9150
Evaluation of Topotecan in Gastric Cancer, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
07-15-1992
Closed
10-15-1993
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
SWOG-8955
Treatment of Stage D, Hormone Refractory Carcinoma of the Prostate with 5/Fluorouracil and Roferon-A®, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-15-1992
Closed
11-01-1993
Closed
Phase
Accrual
35%
SWOG Clinical Trial Number
SWOG-9147
Evaluation of Tamoxifen in Desmoid Tumors, Phase II
Activated
06-01-1992
Closed
08-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9116
Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II
Activated
06-01-1992
Closed
10-01-1993
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
SWOG-9124
Evaluation of Edatrexate (EDX) in Patients with Relapsed or Refractory Germ Cell Tumors, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-01-1992
Closed
09-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9032
A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia
Research Committee(s)
Leukemia
Activated
06-01-1992
Closed
03-01-1998